SE417961B - Forfarande for framstellning av foreningar, som er antagonister mot vissa verkningar av histamin - Google Patents

Forfarande for framstellning av foreningar, som er antagonister mot vissa verkningar av histamin

Info

Publication number
SE417961B
SE417961B SE7507364A SE7507364A SE417961B SE 417961 B SE417961 B SE 417961B SE 7507364 A SE7507364 A SE 7507364A SE 7507364 A SE7507364 A SE 7507364A SE 417961 B SE417961 B SE 417961B
Authority
SE
Sweden
Prior art keywords
societies
histamine
procedure
preparation
against certain
Prior art date
Application number
SE7507364A
Other languages
English (en)
Other versions
SE7507364L (sv
Inventor
G J Durant
C R Ganellin
G R Owen
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of SE7507364L publication Critical patent/SE7507364L/sv
Publication of SE417961B publication Critical patent/SE417961B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/16Compounds containing any of the groups, e.g. aminoguanidine
    • C07C281/18Compounds containing any of the groups, e.g. aminoguanidine the other nitrogen atom being further doubly-bound to a carbon atom, e.g. guanylhydrazones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/26Radicals substituted by sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28Radicals substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE7507364A 1974-06-28 1975-06-26 Forfarande for framstellning av foreningar, som er antagonister mot vissa verkningar av histamin SE417961B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB28722/74A GB1497260A (en) 1974-06-28 1974-06-28 Guanidine derivatives

Publications (2)

Publication Number Publication Date
SE7507364L SE7507364L (sv) 1975-12-29
SE417961B true SE417961B (sv) 1981-04-27

Family

ID=10280055

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7507364A SE417961B (sv) 1974-06-28 1975-06-26 Forfarande for framstellning av foreningar, som er antagonister mot vissa verkningar av histamin

Country Status (20)

Country Link
US (1) US4034101A (sv)
JP (1) JPS5946221B2 (sv)
AU (1) AU503858B2 (sv)
BE (1) BE830272A (sv)
CA (1) CA1076579A (sv)
CH (1) CH615669A5 (sv)
DE (1) DE2528639A1 (sv)
DK (1) DK268975A (sv)
ES (1) ES438944A1 (sv)
FR (1) FR2276042A1 (sv)
GB (1) GB1497260A (sv)
IE (1) IE41625B1 (sv)
IL (1) IL47394A (sv)
LU (1) LU72835A1 (sv)
NL (1) NL7506951A (sv)
NO (1) NO143942C (sv)
PH (1) PH14275A (sv)
PL (1) PL98616B1 (sv)
SE (1) SE417961B (sv)
ZA (1) ZA753455B (sv)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5014808U (sv) * 1973-06-06 1975-02-17
JPS55822B2 (sv) * 1973-07-09 1980-01-10
GB1493931A (en) * 1974-02-07 1977-11-30 Smith Kline French Lab Guanidines isothioureas and thioureas
US4197305A (en) * 1974-02-07 1980-04-08 Smith Kline & French Laboratories Limited Thiazole, isothiazole, oxazole and isoxazole compounds
US4133886A (en) * 1974-02-07 1979-01-09 Smith Kline & French Laboratories Limited Guanidino, thioureido, isothioureido and nitrovinylamino derivatives of pyridine
US4170652A (en) * 1974-03-12 1979-10-09 Smith Kline & French Laboratories Limited Heterocyclic-methylthioalkyl-guanidines
GB1496787A (en) * 1974-03-12 1978-01-05 Smith Kline French Lab Heteroalkylthioalkyl amidine derivatives
JPS5912767Y2 (ja) * 1974-03-28 1984-04-17 アイワ カブシキガイシヤ 回転機器の作動切換装置
US4093729A (en) * 1974-06-28 1978-06-06 Smith Kline & French Laboratories Limited N-Oxy and N-amino guanidines
US4192879A (en) * 1975-05-21 1980-03-11 Smith Kline & French Laboratories Limited Imidazolyl alkylamino nitroethylene compounds
IL49528A (en) * 1975-05-21 1980-11-30 Smith Kline French Lab Imidazolyl(or thiazolyl)methylthio(or butyl)guanidine or thiourea derivatives,their preparation and pharmaceutical compositions comprising them
GB1564502A (en) * 1975-07-31 1980-04-10 Smith Kline French Lab Guanidines thioureas and 1,1-diamino-2-nitroethylene derivatives
US4165378A (en) 1977-04-20 1979-08-21 Ici Americas Inc. Guanidine derivatives of imidazoles and thiazoles
NZ186965A (en) 1977-04-20 1980-02-21 Ici Ltd Guanidino derivatives and pharmaceutical compositions
GB1602458A (en) * 1977-05-05 1981-11-11 Smith Kline French Lab Bisamidines as histamine h2-antagonists
US4108859A (en) * 1977-06-06 1978-08-22 The Dow Chemical Company Microbicidal (pyridinylamino) alkyl guanidines
US4233302A (en) 1977-12-23 1980-11-11 Glaxo Group Limited Amine derivatives and pharmaceutical compositions containing them
DE2963363D1 (en) 1978-05-24 1982-09-09 Ici Plc Antisecretory thiadiazole derivatives, processes for their manufacture and pharmaceutical compositions containing them
EP0010893B1 (en) * 1978-10-16 1984-02-08 Imperial Chemical Industries Plc Antisecretory branched-chain heterocyclic guanidine derivatives, processes for their manufacture, intermediates, and pharmaceutical compositions containing said derivatives
JPS56124143A (en) * 1980-02-29 1981-09-29 Sanyo Electric Co Ltd Control mechanism of tape recorder
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives
JPS6156012U (sv) * 1984-09-19 1986-04-15
JPS61228914A (ja) * 1985-04-04 1986-10-13 Sumitomo Heavy Ind Ltd 成形用金型
JPH0347862Y2 (sv) * 1985-12-14 1991-10-14
WO2022034121A1 (en) 2020-08-11 2022-02-17 Université De Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE758146A (fr) * 1969-10-29 1971-04-28 Smith Kline French Lab Derives de l'amidine
GB1338169A (en) * 1971-03-09 1973-11-21 Smith Kline French Lab Ureas thioureas and guanidines

Also Published As

Publication number Publication date
IL47394A0 (en) 1975-07-28
AU8230475A (en) 1976-12-23
NL7506951A (nl) 1975-12-30
FR2276042A1 (fr) 1976-01-23
DE2528639A1 (de) 1976-01-15
AU503858B2 (en) 1979-09-27
SE7507364L (sv) 1975-12-29
BE830272A (fr) 1975-12-16
US4034101A (en) 1977-07-05
CA1076579A (en) 1980-04-29
JPS5119766A (sv) 1976-02-17
LU72835A1 (sv) 1975-10-08
JPS5946221B2 (ja) 1984-11-10
NO143942C (no) 1981-05-13
IE41625L (en) 1975-12-28
PL98616B1 (pl) 1978-05-31
PH14275A (en) 1981-04-29
IL47394A (en) 1980-01-31
ES438944A1 (es) 1977-02-16
FR2276042B1 (sv) 1980-04-25
ZA753455B (en) 1976-04-28
NO143942B (no) 1981-02-02
IE41625B1 (en) 1980-02-13
GB1497260A (en) 1978-01-05
DK268975A (da) 1975-12-29
CH615669A5 (sv) 1980-02-15
NO752330L (sv) 1975-12-30

Similar Documents

Publication Publication Date Title
SE419544B (sv) Forfarande for framstellning av foreningar, som er antagonister mot vissa verkningar av histamin
SE417961B (sv) Forfarande for framstellning av foreningar, som er antagonister mot vissa verkningar av histamin
SE409707B (sv) Forfarande for framstellning av sulfoxider, vilka er antagonister mot vissa verkningar av histamin
SE7505040L (sv) Forfarande for framstellning av n-fosfonometylglycin.
SE416202B (sv) Forfarande for framstellning av foreningar vilka er antagonister mot vissa verkningar av histamin
SE416050B (sv) Forfarnde for framstellning av foreningar, som er antagonister mot vissa verkningar av histamin
SE7503689L (sv) Forfarande for framstellning av 1,1-diaryl-1-oxadiazol-alkylaminer
SE409452B (sv) Forfarande for framstellning av stilbenderivat
NO146199C (no) Fremgangsmaate for fremstilling av alfa-6-deoksy-5-hydroksytetracyklin-hydroklorid
SE7506237L (sv) Forfarande for framstellning av dekahydroisokinolinderivat
SE403477B (sv) Forfarande for famstellning av substituerade indoleniner
SE410103B (sv) Forfarande for framstellning av foreningar, vilka er antagonister mot vissa verkningar av histamin
SE7513739L (sv) Forfarande for framstellning av 2-scyl-4-oxo-pyrazino-isokonolin-derivat
IT1041584B (it) Procedimento per la preparazione dell idrazodicarbonammide
AR208548A1 (es) Procedimiento para la preparacion de derivados de n-butilamina
SE388854B (sv) Forfarande for framstellning av fenylpyridylaminderivat
SE7506196L (sv) Forfarande for framstellning av amidin-hydrazon-derivat
NO139684C (no) Fremgangsmaate for fremstilling av n,n-diallyldikloracetamid
SE7512422L (sv) Forfarande for framstellning av 1,2,3,4-tetrahydroisokinoliner
SE7709402L (sv) Forfarande for framstellning av tetrahydropyridinderivat
SE7600847L (sv) Nytt forfarande for framstellning av 8-bromtienotriazolo-1,4-diazepiner
NO143626C (no) Fremgangsmaate til fremstilling av 2-alkyl-5-nitroimidazolderivater.
SE7508742L (sv) Forfarande for framstellning av eten-propenbutadien-terpolymerer
SE7507482L (sv) Forfarande for framstellning av substituerade l-sulfonylbensimidazoler.
SE408898B (sv) Foerfarande foer framstaelling av en 17-monoester av 17alfa, 21-dihydroxisteroider